Would you offer adjuvant chemotherapy for platinum eligible patients with pT2pN0 urothelial carcinoma of bladder or UTUC who did not receive neoadjuvant chemotherapy?
If so, what regimen would you use? Would a carboplatin-based regimen be acceptable or only cisplatin?